Celldex Therapeutics (CLDX) PT Raised to $100 at Guggenheim
Tweet Send to a Friend
(Updated - July 20, 2026 7:14 AM EDT)
Guggenheim analyst Yatin Suneja raised the price target on Celldex Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja raised the price target on Celldex Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


